Cheelcare (TSXV: CHER) has reported earnings for its fourth quarter and fiscal year ending April 30, 2026.
In an Aug. 31 update, the Markham, Ontario-based manufacturer said fiscal 2026 revenue was up 22% to $1.9 million CAD (approximately $1.372 million U.S.). Cheelcare said it sold 536 Companion power-assist systems for the year, compared to 453 units sold in fiscal 2025, for an 18% increase in annual unit sales.
Cheelcare now has sold more than 2,000 Companion power-assist systems since its launch, “reflecting continued market acceptance and expansion of Cheelcare’s dealer and distribution network,” the announcement noted.
The company has more than 500 provider locations around the world, including more than 200 in the United States and 267 providers in Ontario. Cheelcare also works with more than 35 Veterans Affairs medical centers.
“Cheelcare transitioned to its new 16,000-sq. ft. production facility during the year, with production operations commencing in October 2025,” the company said, adding it “continued to optimize manufacturing processes and production workflows to support increased capacity and future commercial growth.”
The earnings report included an update on Curio, which Cheelcare describes as its “robotic Complex Rehab power wheelchair.”
“Following its most recent review under Ontario’s Assistive Devices Program (ADP), the company is undertaking additional product refinement and validation prior to resubmission, while continuing to advance the U.S. FDA 510(k) pre-market notification process,” Cheelcare said.
Curio features auto-leveling seating, seat elevation, and tilt (posterior, anterior, lateral) and can accommodate alternative driving controls. The power chair weighs approximately 200 lbs.
